• ABOUT
  • CONTRIBUTORS
  • PROJECT FDA
  • CATEGORIES
    Conflict of Interest Regulation Consumer Driven Health Care Drug Importation and Price Controls Drug and Medical Device Litigation FDA Regulation & Medical Innovation Intellectual Property Rights and Innovation Medicare and Medicaid Personalized Medicine Value of Medicine
  • SPOTLIGHT
    Archive
  • SECOND OPINION
  • PODCASTS
  • REPORTS

Archives

Monthly Archives

  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • July 2011
  • June 2011

Categories

  • Conflict of Interest Regulation
  • Consumer Driven Health Care
  • Drug Importation and Price Controls
  • Drug and Medical Device Litigation
  • FDA Regulation & Medical Innovation
  • Intellectual Property Rights and Innovation
  • Medicare and Medicaid
  • Personalized Medicine
  • Pharmaceutical Advertising, Communication, and Labeling
  • Value of Medicine

Search


keep in touch     Follow Us on Twitter  Facebook  Facebook

Recent Entries

  • Get FDA Off the Slow Track
  • Health Savings Accounts on the Obamacare Exchanges: Early Warning Signs for HSAs - and the Exchanges
  • A Prescription for Medicaid
  • A Model Medicare Program
  • FDA Reform Can Lift U.S. Economy
  • Here Comes The Boom: CMS Slashes Medicare Advantage; 'Disarray For Many Seniors'
  • Is Big Pharma Hiding Data?
  • Manhattan Moment: President Obama's bait and switch
  • Why Does FDA Keep Drugmakers From Informing Doctors?
  • Column: Potential ObamaCare privacy nightmare
home   about   project fda   spotlight   second opinion   events   contact   links
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org